ACG brings patient-friendly access and ultra-high barrier protection together in blister packaging
ACG’s CR/SF lidding foil and Ultrasafe thermoformable film address two critical blister-packaging requirements: making individual doses accessible to intended users while protecting formulations from oxygen and moisture.
Pharmaceutical blister packaging must protect the medicine throughout its shelf life, but it must also work effectively at the patient-product interface. ACG’s CR/SF foil and Ultrasafe film can be positioned as complementary packaging technologies addressing these separate but closely connected needs.
ACG’s CR/SF foil is designed for child-resistant and senior-friendly blister packs. Its lidding mechanism is intended to make blisters more difficult for children to open while remaining straightforward for older users. The foil is available for peelable, peel-push, cut-open and push-through applications, allowing the opening format to be selected according to the product and target patient population.
ACG also lists protection for individual doses, customised surface and reverse printing, and PVC-free and halogen-free structure options among the foil’s features. Its range includes structures designed to seal with PVC and PVdC blister materials.
Ultrasafe addresses the product-protection side of the pack. It is an ultra-high-barrier thermoformable film made by coating pharmaceutical-grade PVC with Diofan® Super B PVdC. ACG states that the material provides strong protection against both oxygen and moisture, as well as a barrier against external aromas and flavours.
The film is designed to form on different packaging lines without specific tooling modifications. Its thermoformability can support greater pill density and smaller blister packs, potentially reducing storage requirements and improving transport efficiency. A low coefficient of friction is also intended to support smooth operation on high-speed machinery.
Presented together, CR/SF foil and Ultrasafe offer a useful editorial story about balancing product integrity, patient safety and usability. Before describing them as a formally validated combined pack, ACG should confirm the exact lidding and base-film structures tested together, along with the relevant sealing parameters.
